Justin G. Trogdon, PhD

This article examines the prevalence of pay-for-performance incentives to promote human papillomavirus vaccination and other quality metrics as reported by frontline clinical staff.

This article used regression analyses to quantify how clinical staff perceive provider feedback to improve human papillomavirus (HPV) vaccination rates and determine the prevalence of such feedback.

Medicare Part D low-income subsidies alone are insufficient to improve the uptake and equitable use of high-cost, orally administered antimyeloma therapy.

State-level estimates of the number of people treated for cancer and the average cost of their treatment by state from 2010 through 2020.

Being actively treated for cancer increases the mean annual out-of-pocket medical expenditures by $1170 compared with not having cancer.